It was reported that during a stent deployment procedure, the white latch at the distal end was allegedly popped out by itself, leading to the failure of the stent to be released.The procedure was completed using another device.The patient experienced pain in leg and decreased oxyhemoglobin saturation; however, the current status of the patient is unknown.
|
It was reported that during a stent deployment procedure, the white latch at the distal end was allegedly popped out by itself, leading to the failure of the stent to be released.The procedure was completed using another device.The patient experienced pain in leg and decreased oxyhemoglobin saturation; however, the current status of the patient is unknown.
|
H10: manufacturing review: a review of manufacturing records was not performed, as additional complaints have not been reported for this lot.Based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.However, the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Investigation summary: the stent delivery system was returned for evaluation in disassembled condition.The conversion tab was missing.It was not known why the grip was disassembled.Based on analysis of the returned sample, the investigation confirmed for detachment.A definite root cause for the reported event could not be determined.Labeling review: in reviewing the relevant labeling it was found that the instructions for use sufficiently address the potential risks.With regards to warnings, the instructions for use states 'visually inspect the bard e-luminexx vascular stent to verify that the device has not been damaged due to shipping or improper storage.Do not use damaged equipment'.Regarding stent placement precautions, the instructions for use states 'do not remove the white conversion tab (m) unless you have selected ¿the conventional method¿ for stent deployment'.With regards to indications for use, the instructions for use states that the stent is to be used on femoral and iliac arteries.Based on reported information, the intended placement site for this stent was the venous system which represents off-label use.H10: d4 (expiry date: 10/2023).H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|